1,908
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Observational Studies in COPD: Summary of Guidance for Authors

, &
Pages 415-417 | Received 27 Nov 2018, Accepted 29 Nov 2018, Published online: 13 Jan 2019
 

Disclosure statement

S. Suissa has participated in advisory boards, as speaker, or received funding from AstraZeneca, Boehringer Ingelheim and Novartis. G. Sotgiu has no conflict of interest to declare. V. Brusasco received research funds from Novartis and fees for speaking at meetings from Novartis, Menarini, AstraZeneca, and Lusofarmaco.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.